BRAIN BIOTECH AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.260 EUR | +0.62% |
|
-1.51% | -8.17% |
| Jan. 14 | BRAIN Biotech AG Reports Earnings Results for the Full Year Ended September 30, 2024 | CI |
| Dec. 12 | BRAIN Biotech AG - Analyst/Investor Day |
Main competitors
| Revenues | Net margin | EBIT margin | ROE | ROA | Leverage | ||
|---|---|---|---|---|---|---|---|
| 60.9M | 20.38% | 16.21% | -62.89x | -13.94x | -2.31x | ||
| 28.17M | 123.20% | 136.74% | -48.78x | - | -2.41x | ||
| Average | 44.54M | percentage-no-prefix | percentage-no-prefix | -55.83x | -13.94x | -2.36x | |
| Weighted average by Cap. | 38.61M | percentage-no-prefix | percentage-no-prefix | -53.28x | -13.94x | -2.38x |
- Stock Market
- Equities
- BNN Stock
- Sector BRAIN Biotech AG
- Financial comparisons